{"data":{"id":"us-in/ic-16-42-26-2","jurisdiction":"us-in","citation":"IC 16-42-26-2","heading":"\"Investigational drug, biological product, or device\"","body":"Sec. 2. As used in this chapter, \"investigational drug, biological product, or device\" means an investigational or experimental:\n(1) drug;\n(2) biological product; or\n(3) medical device;\nthat has successfully completed Phase I of a federal Food and Drug Administration approved clinical trial, but has not been approved for general use by the federal Food and Drug Administration and remains under investigation in a clinical trial.","path":["TITLE 16. HEALTH","ARTICLE 42. REGULATION OF FOOD, DRUGS, AND COSMETICS","Chapter 26. Drugs: Investigational Drug, Biological Product, or Device"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-42-26-2","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"9efed1f64114ad47081b57f8102bfd0206ffa214bbec57a449cb65a0b287b18f","source_id":"us-in","stale":false,"prev":"us-in/ic-16-42-26-1","next":"us-in/ic-16-42-26-3"},"notice":"GroundRules: Original legal text. Not legal advice."}